The Utilization of Inclisiran for the Optimization of Lipid Management in People Living with HIV: A Clinical Case Series and Comprehensive Review. [PDF]
Petrakis V +4 more
europepmc +1 more source
A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet<sup>®</sup> tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol. [PDF]
Joung KH, Ku BJ.
europepmc +1 more source
Case Report - Anti-HMGCR-Associated Immune-Mediated Necrotizing Myopathy and Interstitial Lung Disease With Long-Term Use of Ezetimibe and Low-Dose Atorvastatin. [PDF]
Finsterer J.
europepmc +1 more source
Treatment Patterns and Healthcare-Related Costs in Patients with Atherosclerotic Cardiovascular Disease: Insights from a Large US Healthcare Insurer. [PDF]
Smith JL +5 more
europepmc +1 more source
Inclisiran-induced LDL-cholesterol reduction with and without concomitant statin therapy: a real-world analysis. [PDF]
Seidel M +6 more
europepmc +1 more source
Amorphous Solid Dispersions for BCS Class II Antihyperlipidemic Drugs: From Drug-Polymer Interactions to in vivo Performance. [PDF]
Ridwan S +3 more
europepmc +1 more source
Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome. [PDF]
Ceasovschih A +17 more
europepmc +1 more source
Enlicitide, a Novel Oral Macrocyclic Peptide PCSK9 Inhibitor for Lipid Lowering: A Systematic Review and Meta-Analysis. [PDF]
Yagmur B, Cekirdekci EI.
europepmc +1 more source

